GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Accounts Payable & Accrued Expense

Halberd (Halberd) Accounts Payable & Accrued Expense : $0.79 Mil (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Accounts Payable & Accrued Expense?

Halberd's quarterly accounts payable & accrued expense increased from Jul. 2008 ($0.07 Mil) to Jul. 2022 ($0.60 Mil) and increased from Jul. 2022 ($0.60 Mil) to Jul. 2023 ($0.79 Mil).

Halberd's annual accounts payable & accrued expense increased from Jul. 2008 ($0.07 Mil) to Jul. 2022 ($0.60 Mil) and increased from Jul. 2022 ($0.60 Mil) to Jul. 2023 ($0.79 Mil).


Halberd Accounts Payable & Accrued Expense Historical Data

The historical data trend for Halberd's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Accounts Payable & Accrued Expense Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Accounts Payable & Accrued Expense
0.07 0.60 0.79

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Accounts Payable & Accrued Expense 0.07 0.60 0.79

Halberd Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Halberd (Halberd) Business Description

Industry
Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236